CRH Medical posted Q3 results after the close. In general the results looked positive with higher adjusted EBITDA attributable to owners ( a good portion is attributable to minority interests) but lower net income attributable to owners. Given the complexities in the financials of this company it’s hard to say how the market will react but I would guess moderately positively. But it does look the actual earnings per share at 0.4 cents per share were lower than the analyst-expected 2 cents. The market reaction will depend on how the results compared overall to expectations (revenue, EBITDA and other line items) and what is said about outlook.